US PTAB Patent Cases
5,620 decisions indexed
Page 17 of 188 · 5,620 total
TankLogix, LLC v.SitePro, Inc.
TankLogix has filed a post‑grant review petition seeking cancellation of all 31 claims of SitePro’s ‘184 patent covering remote control of fluid‑handling equipment, arguing abstract‑idea ineligibility, obviousness over four prior references, and lack of written‑description support.
BOE Technology Group Co., Ltd. v.Paneltouch Technologies LLC
The USPTO Board issued mixed institution decisions across multiple IPR and PGR proceedings, granting trials in some cases while denying them in others based on likelihood of prevailing.
United Therapeutics Corporation v.Actelion Pharmaceuticals Ltd. et al.
United Therapeutics has filed an IPR petition seeking cancellation of all 57 claims of Actelion’s ’847 patent covering macitentan‑PDE5 inhibitor combinations for pulmonary hypertension. The petition alleges anticipation by Bolli and obviousness over Bolli‑Keyser and Hoeper‑Morice references, arguing that secondary considerations are irrelevant.
Belden Inc. et al. v.CommScope Technologies LLC
Belden, PPC Broadband, and Opterna have filed an IPR petition challenging 29 claims of CommScope’s ’417 fiber‑optic enclosure patent, asserting obviousness over Hogan, Walters, and Abel. The petition seeks institution and cancellation of the claims.
Belden Inc. et al. v.CommScope Technologies LLC
The PTAB denied institution for IPR2025-01119 involving Belden Inc. et al. and CommScope Technologies LLC, finding the petitioner failed to meet the reasonable likelihood of prevailing standard.
Google LLC v.Cellular South Inc
The PTAB denied Google’s request to rehear its challenge to Cellular South’s facial‑recognition patent, finding no abuse of discretion. The Board held that the petitioner failed to raise a proper claim‑construction issue and that its new arguments were untimely and overly broad.
Google LLC v.Cellular South Inc
Google’s request for Director Review of a PTAB denial of institution is challenged by Cellular South, which argues the Board correctly applied the settled‑expectations doctrine and exercised its discretionary authority under § 314(a). The response stresses that the arguments are not new and have been previously rejected.
Google LLC v.Cellular South Inc
The USPTO denied Google’s request for Director Review of the institution denial in IPR2025-00875, keeping the challenge against Cellular South’s patent alive.
Google LLC v.Cellular South Inc
Google LLC has filed a petition for Director Review challenging the USPTO’s denial of institution for its IPR against Cellular South’s 9,940,972 patent. The petition argues that the Board’s “settled expectations” rule exceeds statutory authority and violates the APA, AIA, and due process.
Google LLC v.Cellular South Inc
An email notifies parties that Director Review requests have been filed for IPR2025-00875 and IPR2025-00876. It outlines a 15‑page response limit, a five‑business‑day deadline, and bars new evidence. The patent owner must respond within the stipulated timeframe.
Google LLC v.Cellular South Inc
Google has filed an IPR petition challenging Cellular South’s 11,126,853 patent covering video‑to‑data systems, asserting that all eleven claims are obvious under §103. The petition lists four grounds, each tying specific claim groups to prior‑art references.
Google LLC v.Cellular South Inc
The PTAB denied Google's request to institute IPR against Cellular South's patent (11,126,853), finding the petitioner failed to establish a reasonable likelihood of success on obviousness grounds.
Cisco Systems, Inc. v.QPRIVACY USA LLC
Cisco has filed a rehearing request after the PTAB director denied institution of its IPR on patent 11,106,824, arguing that a prior Sotera stipulation eliminates concerns of duplicate litigation. The petition cites Federal Circuit case law to support its position.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol and Credo have settled their dispute over U.S. Patent No. 10,877,233 and jointly moved to terminate the inter partes review. The motion cites 35 U.S.C. § 317 and argues that no merits decision has been made. The Board is asked to end the proceeding.
Cisco Systems, Inc. v.QPRIVACY USA LLC
The USPTO denied Cisco’s request for rehearing of the Director’s discretionary denial and institution denial in two IPRs involving QPRIVACY USA’s patent 11,106,824. The order upholds the earlier decisions.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
Align Technology seeks Director review to vacate the institution of IPR2025-00817 against its intraoral scanner patent. The petitioner’s earlier trial‑date projection is shown to be inaccurate, the cited prior art does not teach the claimed limitation, and the petitioner failed to disclose all foreign real parties in interest.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
The USPTO denied ClearCorrect’s request for Director Review of the institution decisions in multiple IPRs against Align Technology’s patents, leaving the institution rulings intact.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect Operating, LLC filed an authorized response opposing Align Technology’s Director Review Request, asserting that the new RPI arguments are untimely and that the Director’s discretionary denial was proper.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol and Credo Technology Group settled four related IPRs before trial, leading the Board to terminate the proceedings and treat the settlement agreement as confidential business information.
Amphenol Corporation v.Credo Technology Group Ltd.
The ITC investigation into switchable‑connectivity phones and tablets was terminated after Ericsson and Apple filed a joint motion to end the case based on a settlement. The Commission found no reason to deny the motion and declined to review the initial determination.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol and Credo have settled their IPR dispute over U.S. Patent 11,032,111 and jointly request that the settlement agreement be kept confidential. The motion cites statutory authority to treat the agreement as business‑confidential information.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol has filed an IPR petition seeking cancellation of all 14 claims of Credo’s ’252 active Ethernet cable patent, arguing obviousness over prior‑art combinations and asserting that discretionary denial is unwarranted.
Cisco Systems, Inc. v.QPRIVACY USA LLC
Cisco has filed an IPR petition seeking to invalidate all 30 claims of QPrivacy’s U.S. 11,816,249 patent on obviousness grounds, relying on three prior‑art patents (Burns, Yang, Guruswamy). The petition argues that the Board should institute trial and rejects any discretionary denial.
Cisco Systems, Inc. v.QPRIVACY USA LLC
Cisco has filed an IPR petition seeking to invalidate QPrivacy’s U.S. 11,106,824 patent, asserting that all 20 claims are obvious over prior‑art IDS patents (Burns, Yang, and Wittenberg). The petition also argues that discretionary denial is inappropriate.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol petitions the PTAB to invalidate Credo’s ’233 active‑cable patent, asserting that prior‑art references render all twenty claims obvious. The petition also argues that discretionary denial is unwarranted.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect has filed a petition to institute an IPR against Align’s 10,791,936 dental scanning patent, asserting that all 20 claims are obvious over prior‑art references. The petition seeks a finding of unpatentability for the entire claim set.
Samsung Electronics Co., Ltd. et al. v.GenghisComm Holdings, LLC
Samsung has filed an IPR petition challenging 18 claims of GenghisComm’s ’508 patent, asserting anticipation and obviousness over Shattil-537 and secondary references Doufexi and Lucent. The petition argues strong merits and cites Fintiv factors to oppose discretionary denial.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol has filed an IPR petition seeking cancellation of all 19 claims of Credo’s ’111 patent covering chip‑to‑module pre‑equalization techniques. The petition relies on obviousness over Lugthart‑706, Das Sharma, and Mezer, and argues that discretionary denial is unwarranted.
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect Operating successfully moved its IPR against Align Technology's dental scanning patent to the trial phase. The Board found a reasonable likelihood of prevailing on at least one claim, leading to institution on all 20 claims.
American Airlines, Inc. et al. v.Intellectual Ventures I LLC
The PTAB denied institution for American Airlines and Southwest Airlines against Intellectual Ventures I LLC, finding the petitioner failed to meet the 'reasonable likelihood' standard under 35 U.S.C. § 314(a). The Board specifically rejected the obviousness arguments concerning partitioning and descriptions limitations based on prior art references Chow, Reiffin, and Kurowski.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.